Cerus (CERS) vs Neuropace (NPCE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Cerus (CERS) has outperformed Neuropace (NPCE) over the past year, gaining 43.1% versus a gain of 19.8%. Over five years, NPCE leads with a -18.6% price change compared with -62.6% for CERS. Cerus is the larger company by market cap ($461.5 million vs $438.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERS | NPCE |
|---|---|---|
| Share price | $2.29 | $12.76 |
| Market cap | $461.49M | $437.98M |
| 1-day change | -2.14% | +0.71% |
| YTD return | +11.17% | -17.36% |
| 1-year return | +43.13% | +19.81% |
| 5-year return | -62.58% | -18.57% |
| EPS (TTM) | $-0.03 | $-0.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.47 | $19.60 |
| 52-week low | $1.38 | $9.22 |
| Distance from 52-week high | -34.01% | -34.90% |
| Average volume | 2.15M | 169.58K |
| Shares outstanding | 201.52M | 34.32M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CERS has outperformed NPCE by 23.3 percentage points over the past year.
CERS vs NPCE FAQ
Which is bigger, Cerus or Neuropace?
Cerus (CERS) is larger, with a market capitalization of $461.49M compared with $437.98M for Neuropace (NPCE).
Which stock has performed better over the past year, CERS or NPCE?
CERS returned +43.13% over the past 12 months, compared with +19.81% for NPCE (price return, excluding dividends). Past performance does not predict future results.
Are Cerus and Neuropace in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.